BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 11383862)

  • 21. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.
    Brouwer OR; van den Berg NS; Mathéron HM; van der Poel HG; van Rhijn BW; Bex A; van Tinteren H; Valdés Olmos RA; van Leeuwen FW; Horenblas S
    Eur Urol; 2014 Mar; 65(3):600-9. PubMed ID: 24355132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive lymphoscintigraphy (ILS) and negative computed tomography for metastatic penile cancer.
    Bantis A; Sountoulides P; Kalaitzis C; Boussios N; Giannakopoulos S; Zissimopoulos A
    Hell J Nucl Med; 2011; 14(3):309-10. PubMed ID: 22087456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma.
    Hadway P; Smith Y; Corbishley C; Heenan S; Watkin NA
    BJU Int; 2007 Sep; 100(3):561-5. PubMed ID: 17578518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
    Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
    Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penile lymphoscintigraphy for sentinel node identification.
    Valdés Olmos RA; Tanis PJ; Hoefnagel CA; Jansen L; Nieweg OE; Meinhardt W; Horenblas S
    Eur J Nucl Med; 2001 May; 28(5):581-5. PubMed ID: 11383862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience.
    Alex JC
    Laryngoscope; 2004 Jan; 114(1):2-19. PubMed ID: 14709988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy in penile cancer: evolution and insights.
    Izawa J; Kedar D; Wong F; Pettaway CA
    Can J Urol; 2005 Feb; 12 Suppl 1():24-9. PubMed ID: 15780161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applications.
    Paganelli G; De Cicco C; Chinol M
    Recent Results Cancer Res; 2000; 157():121-9. PubMed ID: 10857166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lymphoscintigraphy for selective sentinel lymphadenectomy.
    Uren RF; Howman-Giles RB; Chung D; Thompson JF
    Cancer Treat Res; 2005; 127():15-38. PubMed ID: 16209076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in penile carcinoma.
    Horenblas S
    Semin Diagn Pathol; 2012 May; 29(2):90-5. PubMed ID: 22641958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiopharmaceuticals in sentinel lymph-node detection - an overview.
    Wilhelm AJ; Mijnhout GS; Franssen EJ
    Eur J Nucl Med; 1999 Apr; 26(4 Suppl):S36-42. PubMed ID: 10199931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of the sentinel node in the treatment and staging of initial cervix cancer].
    Paredes P; Vidal-Sicart S; García S; Pahisa J; Torné A; Ordi J; Fuertes S; Ortega M; Pons F
    Rev Esp Med Nucl; 2004; 23(4):253-8. PubMed ID: 15207209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel Node Methods in Penile Cancer - a Historical Perspective on Development of Modern Concepts.
    Jakobsen JK
    Semin Nucl Med; 2022 Jul; 52(4):486-497. PubMed ID: 34933740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally invasive evaluation of the clinically negative inguinal node in penile cancer: Dynamic sentinel node biopsy.
    Wever L; de Vries HM; van der Poel H; van Leeuwen F; Horenblas S; Brouwer O
    Urol Oncol; 2022 Jun; 40(6):209-214. PubMed ID: 33218920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in Preparation of Albumin Nanoparticle-Based Radiopharmaceuticals.
    Ballinger JR
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of clinically node-negative groin in patients with penile cancer.
    Niyogi D; Noronha J; Pal M; Bakshi G; Prakash G
    Indian J Urol; 2020; 36(1):8-15. PubMed ID: 31983820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoscintigraphy in oncology: a rediscovered challenge.
    Valdés Olmos RA; Hoefnagel CA; Nieweg OE; Jansen L; Rutgers EJ; Borger J; Horenblas S; Kroon BB
    Eur J Nucl Med; 1999 Apr; 26(4 Suppl):S2-S10. PubMed ID: 10199926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?
    Brouwer OR; van der Poel HG; Bevers RF; van Gennep EJ; Horenblas S
    Clin Transl Imaging; 2016; 4(5):395-410. PubMed ID: 27738628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.